LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that leading independent proxy…
Voretigene neparvovec shows light sensitivity improvement
PARIS — A 5-year interim analysis of the PERCEIVE real-world study showed sustained improvement of light sensitivity in patients treated with voretigene neparvovec.“This is the biggest real-world analysis of voretigene neparvovec,” Dominik Fischer, MD,…
HALT Max technology boosts effect of Essilor Stellest 2.0 lenses
Essilor Stellest 2.0 lenses with HALT Max technology led to significantly slower axial elongation than standard Essilor Stellest lenses, according to a study published in Translational Vision Science & Technology.Essilor Stellest lenses slow myopia pro…
Organic chemistry returns
That’s right — organic chemistry.You thought you were done with orgo. Admit it, the first thing you did after reading the headline of this column was sprint to your safe spot. You were so traumatized by the mere mention of organic chemistry that you pu…
Organic chemistry returns
That’s right — organic chemistry.You thought you were done with orgo. Admit it, the first thing you did after reading the headline of this column was sprint to your safe spot. You were so traumatized by the mere mention of organic chemistry that you pu…
Biosimilars for Retina and Inflammatory Disease Get EMA Nod
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, efficacy, and cost-effectiveness compared with reference drugs. Medscape News Europe